Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
Interventions: DRUG: Palbociclib + Letrozole or Fulvestrant
Sponsor: Georgetown University
Collaborators: University of Chicago|Thomas Jefferson University